VIRIDIAN THERAPEUTICS INC (VRDN) Stock Analyst Ratings
NASDAQ:VRDN - Nasdaq - US92790C1045 - Common Stock
ChartMill assigns a Buy % Consensus number of 85% to VRDN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 41.25. This target is 127.75% above the current price.
VRDN was analyzed by 23 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about VRDN.
In the previous month the buy percentage consensus was at a similar level.
VRDN was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-07 | Needham | Reiterate | Buy -> Buy |
| 2024-12-19 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2024-12-17 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-12-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-11-25 | TD Cowen | Initiate | Buy |
| 2024-11-25 | Needham | Reiterate | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-11-13 | Needham | Reiterate | Buy -> Buy |
| 2024-10-28 | Needham | Reiterate | Buy -> Buy |
| 2024-09-26 | BTIG | Maintains | Buy -> Buy |
| 2024-09-19 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-13 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-09-12 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-09-11 | Needham | Maintains | Buy -> Buy |
| 2024-09-10 | BTIG | Maintains | Buy -> Buy |
| 2024-09-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-30 | Needham | Reiterate | Buy -> Buy |
| 2024-08-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-07-29 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-11 | Wolfe Research | Initiate | Outperform |
| 2024-06-11 | Needham | Reiterate | Buy -> Buy |
| 2024-06-06 | Goldman Sachs | Initiate | Buy |
| 2024-05-09 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-05-09 | Needham | Reiterate | Buy -> Buy |
| 2024-05-09 | Oppenheimer | Maintains | Outperform -> Outperform |